MPR Weekly Dose Podcast #270 High-dose Wegovy now available for additional weight reduction when clinically indicated; trial results for durvalumab combo treatment in patients with unresectable hepatocellular; generic dapaglifloz...

📢 Latest MPR Pod out now!
🔹High-dose #Wegovy now available;
🔸Results for durvalumab combo in patients with unresectable HCC;
🔹Generic dapagliflozin gets green light, paving way for manufacturers; and
🔸Achondroplasia treatment #Yuviwel now available.
www.empr.com/news/mpr-wee...

💊 The FDA has approved #Yuviwel (navepegritide) for children with achondroplasia. Accelerated approval was based on improved annualized growth velocity in a randomized clinical trial.

📚 Find the clinical evidence for Yuviwel® here: drugdocs.com/drug/Yuviwel